GlassScriptPhysician profile
Bianca Falcone
NPI 1316301260
$1,092.73
in general payments reported to CMS, 2019-2025
15 companies · $53.57 in 2025
The $53.57 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.00 · 2020: $156 · 2021: $420 · 2022: $146 · 2023: $141 · 2024: $164 · 2025: $53.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $207.16 | 2020-2023 | Fluent Fluid Management System, Coolseal Generator |
| Abbvie INC. | $156.63 | 2021-2023 | |
| Gynesonics, INC. | $145.28 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Intuitive Surgical, INC. | $141.11 | 2020-2025 | |
| Therapeuticsmd, INC. | $83.11 | 2021-2022 | |
| Organon LLC | $80.24 | 2021-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $71.57 | 2021-2023 | |
| Exeltis, USA INC. | $64.23 | 2021-2023 | Slynd |
| Myovant Sciences INC. | $35.11 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $28.29 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.78 | 2022 | |
| Lupin INC. | $14.34 | 2021 | |
| Boston Scientific Corporation | $13.65 | 2021 | |
| Shield Therapeutics INC | $13.23 | 2023 | Accrufer |
| Alexion Pharmaceuticals, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Falcone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.